Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request

Bariatric Surgery Reverses ORG and Exhibits a Distinct Transcriptomic Profile Compared to Weight Loss Through a Low-Fat Diet.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
  • معلومة اضافية
    • المصدر:
      Publisher: MDPI Country of Publication: Switzerland NLM ID: 101092791 Publication Model: Electronic Cited Medium: Internet ISSN: 1422-0067 (Electronic) Linking ISSN: 14220067 NLM ISO Abbreviation: Int J Mol Sci Subsets: MEDLINE
    • بيانات النشر:
      Original Publication: Basel, Switzerland : MDPI, [2000-
    • الموضوع:
      Bariatric Surgery*/methods ; Obesity*/complications ; Obesity*/surgery ; Obesity*/genetics ; Kidney Diseases*/etiology ; Kidney Diseases*/genetics ; Kidney Diseases*/pathology ; Weight Loss* ; Transcriptome* ; Diet, Fat-Restricted*; Diet, High-Fat/adverse effects ; Kidney/pathology ; Kidney/metabolism ; Animals ; Male ; Rats ; Rats, Wistar ; Gene Expression Profiling
    • نبذة مختصرة :
      Weight loss is central to treating obesity-related kidney disease, yet the renal effects of a low-fat diet (LFD) versus bariatric surgery (BS) remain incompletely understood. This study compared their impact on obesity-related glomerulopathy (ORG). Twenty-eight male Wistar rats were fed a high-fat diet (HFD) for 10 weeks to induce obesity. Eight rats were sacrificed (the HFD group), eight switched to LFD for 10 weeks, and twelve underwent sleeve gastrectomy. Body weight, albuminuria, renal histology, and transcriptomic profiles were analyzed. Weight loss was modest in the LFD group (-1.6%) but substantial after BS (-13.2%), occurring 2.1 times faster. Albuminuria decreased in both interventions compared to HFD (LFD: 7228 ± 514 ng/mL; BS: 6242 ± 418 ng/mL; HFD: 10,384 ± 1168 ng/mL; p < 0.01) and correlated strongly with weight loss (R2 = 0.78). The glomerular area was reduced in both groups, but only BS achieved complete histological resolution of ORG. Tubular cells in BS-treated rats showed megamitochondria and cristae disruption, while LFD induced milder alterations. Transcriptomics revealed suppression of mitochondrial maintenance genes and upregulation of oxidative stress and immunometabolic pathways. Immune-related genes upregulated in BS clustered into pro-inflammatory/chemotactic and regulatory modules. To the best of our knowledge, this is the first piece of evidence that BS fully reverses ORG, highlighting renal effects beyond weight loss alone.
    • References:
      Kidney Int. 2016 Jul;90(1):164-71. (PMID: 27181999)
      Biomedicines. 2025 Apr 24;13(5):. (PMID: 40426859)
      BMC Biol. 2025 Jan 23;23(1):23. (PMID: 39849579)
      JAMA Surg. 2020 Aug 1;155(8):e200420. (PMID: 32492126)
      Kidney Int. 2017 Feb;91(2):451-458. (PMID: 27914704)
      Obes Rev. 2022 Jul;23(7):e13450. (PMID: 35362662)
      Immunology. 2024 Mar;171(3):365-376. (PMID: 38013255)
      Cells. 2022 Sep 15;11(18):. (PMID: 36139454)
      Nutrients. 2021 Dec 28;14(1):. (PMID: 35010991)
      Front Endocrinol (Lausanne). 2024 Nov 25;15:1488715. (PMID: 39655345)
      Am J Physiol Renal Physiol. 2000 May;278(5):F817-22. (PMID: 10807594)
      Int J Mol Sci. 2024 Jun 11;25(12):. (PMID: 38928144)
      Obes Surg. 2022 Jul;32(7):2397-2402. (PMID: 35524905)
      Kidney Int. 2017 May;91(5):1224-1235. (PMID: 28187985)
      Int J Obes (Lond). 2024 Jan;48(1):103-110. (PMID: 37833561)
      Expert Rev Endocrinol Metab. 2018 Sep;13(5):251-262. (PMID: 30231777)
      Nephron. 2019;143(1):38-42. (PMID: 30947190)
      J Immunol. 2000 May 15;164(10):4991-5. (PMID: 10799849)
      Biochim Biophys Acta. 2014 Mar;1842(3):446-62. (PMID: 23707515)
      Postgrad Med. 2022 May;134(4):359-375. (PMID: 35315311)
      Obes Surg. 2024 Apr;34(4):1257-1266. (PMID: 38396260)
      Front Endocrinol (Lausanne). 2024 Jan 31;15:1320627. (PMID: 38362272)
      Obes Surg. 2021 Aug;31(8):3476-3482. (PMID: 34061302)
      Cytokine Growth Factor Rev. 2020 Oct;55:86-93. (PMID: 32499193)
      Kidney Int. 2001 Apr;59(4):1498-509. (PMID: 11260414)
      Obes Surg. 2024 Jun;34(6):2042-2053. (PMID: 38653888)
      N Engl J Med. 2007 Aug 23;357(8):741-52. (PMID: 17715408)
      Diabetes Obes Metab. 2022 Aug;24(8):1553-1564. (PMID: 35441470)
      Clin Kidney J. 2022 Feb 10;15(6):1204-1208. (PMID: 35664262)
      JAMA Netw Open. 2025 Jan 02;8(1):e2457349. (PMID: 39888616)
      Front Nutr. 2022 Jun 24;9:925619. (PMID: 35811945)
      BMJ Open Diabetes Res Care. 2020 Jul;8(1):. (PMID: 32747384)
      PLoS One. 2016 Oct 4;11(10):e0163907. (PMID: 27701452)
      Clin Kidney J. 2020 Dec 23;14(9):2037-2046. (PMID: 34476090)
      J Am Soc Nephrol. 2006 Dec;17(12 Suppl 3):S213-7. (PMID: 17130264)
      Adv Exp Med Biol. 2019;1189:53-84. (PMID: 31758531)
      Obesity (Silver Spring). 2015 Jul;23(7):1460-71. (PMID: 26097021)
      J Clin Med. 2022 Jan 29;11(3):. (PMID: 35160179)
      Obes Surg. 2007 Jul;17(7):957-61. (PMID: 17894157)
      Eur J Clin Invest. 2016 Sep;46(9):757-65. (PMID: 27296149)
      Nat Rev Nephrol. 2016 Aug;12(8):453-71. (PMID: 27263398)
      Metabolites. 2022 Oct 12;12(10):. (PMID: 36295869)
      Kidney Int Rep. 2020 Jun 02;5(8):1126-1128. (PMID: 32779639)
      Front Med (Lausanne). 2023 Feb 28;10:1134644. (PMID: 36926320)
    • Grant Information:
      PI18-01951 Instituto de Salud Carlos III
    • Contributed Indexing:
      Keywords: Wistar rats; bariatric surgery; low-fat diet; obesity glomerulopathy reversion; obesity-related glomerulopathy; transcriptomic changes
    • الموضوع:
      Date Created: 20260128 Date Completed: 20260128 Latest Revision: 20260131
    • الموضوع:
      20260131
    • الرقم المعرف:
      PMC12841304
    • الرقم المعرف:
      10.3390/ijms27020839
    • الرقم المعرف:
      41596487